pancreatitis%20-%20chronic
PANCREATITIS - CHRONIC
Chronic pancreatitis develops from irreversible scarring sustained by the pancreas from prolonged inflammation.
Signs and symptoms include abdominal pain that is epigastric in location that radiates to the back and frequently occurs at night or after meals, symptoms of fat, protein & carbohydrates maldigestion that become apparent with advanced chronic pancreatitis and presence of diarrhea.
Chronic pancreatitis results in destruction of alpha and beta cells which gives rise to deficiencies of both insulin and glucagon.
Drug Information

Indication: Peptic ulcer disease associated w/ Helicobacter pylori.

Indication: Healing & maintenance of erosive or ulcerative GERD. Healing of duodenal ulcers. Pathological hypersecreto...

Indication: Active duodenal, benign gastric, stomal & recurrent ulceration, persistent dyspeptic symptoms w/ or w/o ul...

Indication: Duodenal & gastric ulcer, reflux esophagitis, Zollinger-Ellison syndrome.

Indication: Duodenal & gastric ulcer, Zollinger-Ellison syndrome & other conditions associated w/ gastric hyperaci...

Indication: Reflux disease & associated symptoms. Prevention of gastroduodenal ulcers induced by NSAIDs in patients at...

Indication: 20 mg Mild GERD & associated symptoms (eg, heartburn, acid regurgitation, pain on swallowing). Long-term m...

Indication: Duodenal & gastric ulcer, reflux oesophagitis, symptomatic GERD, Zollinger-Ellison syndrome. Prophylaxis &...

Dosage: Duodenal ulcer 20-40 mg once daily for 2-4 wk. H pylori eradication Triple therapy regimens: Losec MUPS 20 mg,

Indication: Nexium Gastric antisecretory treatment when oral route is not possible eg, GERD in patients w/ oesophagitis &a...

1  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 6 days ago
Adding periodontal therapy (periotherapy) to standard triple antibiotic therapy targeting Helicobacter (H.) pylori may reduce the risk of recurrence of H. pylori infections, a new study shows, suggesting a promising approach for managing H. pylori infection.
Elaine Soliven, 23 Jan 2019
Older patients receiving treatment for ulcerative colitis (UC) were more likely to experience adverse events (AEs) compared with their younger counterparts, according to a study presented at AIBD 2018.